The Georgetown Company Plans Manhattan Life Sciences Center

The Georgetown Company is planning to construct a 185,000-sf life sciences center in the Hell's Kitchen district of Manhattan in New York City. Created in partnership with Beacon Capital and ZoE Life Sciences, the seven-story facility will provide purpose-built research environments for biomedical and pharmaceutical tenants. The highly collaborative structure will offer flexible floorplates starting at 31,000 sf that can accommodate a variety of lab and office configurations.

Designed by Elkus Manfredi Architects, the project involves the redevelopment of a 160,000-sf office building that was purchased in 2022 for approximately $95 million. JLL is acting as leasing agent for the center, which will feature private terraces and floor-to-ceiling windows. Shared amenities including a multifunctional conference venue and numerous breakout areas will enhance interaction between occupants, complemented by a vibrant lobby with a day-to-night café and wine bar.

Targeting LEED Gold and WELL certifications, the sustainable facility will leverage rooftop photovoltaic arrays and advanced mechanical and electrical systems to achieve superior energy performance. The New York City Industrial Development Agency is supporting the project with the New York City Economic Development Corporation providing management services. Construction will begin in summer of 2026 with occupancy slated for 2026.